세계 여성 건강 시장 규모는 2034년까지 연평균 4.6%의 성장률을 나타낼 것으로 예상됩니다.
여성의 건강 문제에 대한 인식 제고:
여성 건강 문제에 대한 인식이 높아지면서 여성 건강 시장이 크게 성장하고 있습니다. 이러한 성장의 배경에는 의료비 지출 증가, 의료 기술 발전, 예방 의료에 대한 관심 증가 등 다양한 요인이 있습니다. 생식 건강, 임산부 건강, 유방 건강, 갱년기 관리, 성 건강 등 여성 특유의 건강 요구를 충족시키는 제품 및 서비스에 대한 수요가 증가하고 있습니다. 또한, 여성 건강 교육 및 옹호 활동을 촉진하는 이니셔티브는 여성 특유의 건강 문제와 조기 발견 및 조기 치료의 중요성에 대한 이해를 높이는 데 기여하고 있습니다. 여성 건강 시장은 지속적으로 확대되고 있으며, 전 세계 여성들에게 혁신과 건강 개선의 기회를 제공할 것으로 예상됩니다.
환자 치료의 기술 발전 :
기술의 발전은 여성 건강 시장의 판도를 빠르게 변화시키고 있으며, 혁신과 환자 치료의 새로운 시대를 열어가고 있습니다. 첨단 진단 도구부터 최첨단 치료법까지, 이러한 발전은 건강 상태를 진단, 관리 및 치료하는 방식에 혁명을 일으키고 있으며, 3D 유방촬영술과 MRI와 같은 첨단 영상 진단 기술은 유방암을 조기에 발견하는 정확도를 높이고 생존율을 향상시키며 침습적 수술의 필요성을 감소시키고 있습니다. 복강경 수술 및 로봇 보조 수술과 같은 최소침습 수술 기술은 자궁내막증 및 자궁근종과 같은 부인과 질환을 치료할 수 있는 보다 안전하고 효과적인 옵션을 제공합니다. 또한, 모바일 앱, 웨어러블 기기, 원격 의료 플랫폼과 같은 디지털 건강 솔루션은 편리한 정보 접근, 모니터링 도구, 의료 서비스 제공업체와의 가상 상담 등을 통해 여성들이 자신의 건강을 관리할 수 있도록 돕고 있습니다. 이러한 기술 혁신은 여성 건강 결과를 개선하고, 시장 성장을 가속하며, 여성 건강 분야의 전반적인 치료의 질을 향상시키는 데 있어 큰 잠재력을 가지고 있습니다.
세계 여성 건강(Women's Health) 시장을 조사했으며, 시장 개요, 시장 성장에 영향을 미치는 요인과 시장 기회 분석, 시장 규모 추이 및 예측, 각 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 전해드립니다.
목차
제1장 보고서 개요
제2장 주요 요약
제3장 시장 개요
주요 조사 결과
시장 역학
시장 추진 요인
시장 성장 억제요인
시장 기회
COVID-19의 영향 분석
Porter의 Five Forces 분석
PEST 분석
제4장 여성 건강 시장 분석 : 용도별
주요 조사 결과
시장의 매력 지수
시장 규모 추이와 예측
피임약
폐경 후 골다공증
호르몬성 불임증
폐경
다낭성 난소증후군
자궁내막증 및 자궁근종
기타
시장 규모 추이와 예측 : 지역별
시장 점유율 : 지역별
제5장 여성 건강 시장 분석 : 유통 채널별
주요 조사 결과
시장의 매력 지수
시장 규모 추이와 예측
병원 약국
소매 약국
온라인 약국
시장 규모 추이와 예측 : 지역별
시장 점유율 : 지역별
제6장 여성 건강 시장 분석 : 의약품별
주요 조사 결과
시장의 매력 지수
시장 규모 추이와 예측
Xgeva
Prolia
Mirena
Nexplanon
Forteo
Nuvaring
Premarin
Lupron
Lo Loestrin
Orilissa/Oriahnn
기타
시장 규모 추이와 예측 : 지역별
시장 점유율 : 지역별
제7장 여성 건강 시장 분석 : 유형별
주요 조사 결과
시장의 매력 지수
시장 규모 추이와 예측
제네릭 의약품
브랜드 의약품
시장 규모 추이와 예측 : 지역별
시장 점유율 : 지역별
제8장 여성 건강 시장 분석 : 지역별
주요 조사 결과
시장 규모 추이와 예측
제9장 북미의 여성 건강 시장 분석
제10장 유럽의 여성 건강 시장 분석
제11장 아시아태평양의 여성 건강 시장 분석
제12장 라틴아메리카의 여성 건강 시장 분석
제13장 중동 및 아프리카의 여성 건강 시장 분석
제14장 기업 개요
경쟁 구도
전략적 전망 : 요약
Abbott Laboratories
Bayer AG
Caldera Medical Inc.
Cardinal Health
Carestream Health
Cooper Surgical Inc.
L. Hoffman-La Roche Ltd.
General Electric Healthcare
Hologic Inc.
koninklijke philips n.v
MedGyn Products Inc.
Medline Industries, Inc.
Prestige Consumer Healthcare Inc.
Siemens AG
제15장 결론 및 제안
Visiongain의 결론
참여 기업을 위한 추천 사항
LSH
영문 목차
영문목차
The global Women's Health market is estimated to grow at a CAGR of 4.6% by 2034
The Women's Health Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Growing awareness about women's health issues
The women's health market is experiencing significant growth due to increasing awareness about women's health issues. This growth is driven by various factors such as rising healthcare expenditures, advancements in medical technology, and a greater focus on preventive care. There is a growing demand for products and services addressing women's unique health needs, including reproductive health, maternal health, breast health, menopause management, and sexual health. Additionally, initiatives promoting women's health education and advocacy have contributed to a greater understanding of gender-specific health concerns and the importance of early detection and treatment. The women's health market is expected to continue expanding, offering opportunities for innovation and improved healthcare outcomes for women worldwide.
Technological advancements in patient care
Technological advancements are rapidly reshaping the landscape of the women's health market, ushering in a new era of innovation and improved patient care. From sophisticated diagnostic tools to cutting-edge treatment modalities, these advancements are revolutionizing the way women's health conditions are diagnosed, managed, and treated. Advanced imaging techniques, such as 3D mammography and MRI, offer greater accuracy in detecting breast cancer at its earliest stages, improving survival rates and reducing the need for invasive procedures. Minimally invasive surgical techniques, including laparoscopy and robotic-assisted surgery, are providing safer and more effective options for addressing gynaecological conditions like endometriosis and fibroids. Moreover, digital health solutions such as mobile apps, wearable devices, and telemedicine platforms are empowering women to take charge of their health by providing convenient access to information, monitoring tools, and virtual consultations with healthcare providers. These technological innovations hold immense promise for enhancing women's health outcomes, driving market growth, and advancing the overall quality of care in the field of women's health.
What Questions Should You Ask before Buying a Market Research Report?
How is the Women's Health Market evolving?
What is driving and restraining the Women's Health Market?
How will each Women's Health submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
How will the market shares for each Women's Health submarket develop from 2024 to 2034?
What will be the main driver for the overall market from 2024 to 2034?
Will leading Women's Health Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
Who are the leading players and what are their prospects over the forecast period?
What are the Women's Health projects for these leading companies?
How will the industry evolve during the period between 2024 and 2034? What are the implications of Women's Health projects taking place now and over the next 10 years?
Is there a greater need for product commercialisation to further scale the Women's Health Market?
Where is the Women's Health Market heading and how can you ensure you are at the forefront of the market?
What are the best investment options for new product and service lines?
What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Women's Health Market today, and over the next 10 years:
Our 351-page report provides 125 tables and 186 charts/graphs exclusively to you.
The report highlights key lucrative areas in the industry so you can target them - NOW.
It contains in-depth analysis of global, regional and national sales and growth.
It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Women's Health Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2034 and other analyses reveal commercial prospects
In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
You will find original analyses, with business outlooks and developments.
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Women's Health prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.
Segments Covered in the Report
By Application
Contraceptives
Postmenopausal osteoporosis
Hormonal infertility
Menopause
Polycystic Ovary Syndrome
Endometriosis and Uterine Fibroids
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Drugs
Prolia
Xgeva
Mirena
Nexplanon
Forteo
Nuvaring
Premarin
Lupron
Lo Loestrin
Orilissa/Oriahnn
Others
By Type
Generics
Branded
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America
U.S.
Canada
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America Latin America
MEA
GCC
South Africa
Rest of MEA
The report also includes profiles and for some of the leading companies in the Women's Health Market, 2024 to 2034, with a focus on this segment of these companies' operations.
Leading companies profiled in the report
Abbott
Bayer AG
Caldera Medical
Cardinal Health
Carestream
Cooper Surgical Inc.
L. Hoffman-La Roche Ltd.
GE Healthcare
Hologic
Koninklijke Philips N.V
MedGyn Products
Medline Industries, Inc.
Prestige Consumer Healthcare, Inc.
Siemens AG
Overall world revenue for Women's Health Market, 2024 to 2034 in terms of value the market will surpass US$ 61.0 billion in 2034, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Women's Health Market, 2024 to 2034 report help you?
In summary, our 350+ page report provides you with the following knowledge:
Revenue forecasts to 2034 for Women's Health Market, 2024 to 2034 Market, with forecasts for material, design, type, delivery and application, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
Revenue forecasts to 2034 for five regional and 16 key national markets - See forecasts for the Women's Health Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
Prospects for established firms and those seeking to enter the market - including company profiles for 14 of the major companies involved in the Women's Health Market, 2024 to 2034.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Women's Health Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.
Table of Contents
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Women's Health Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Heightened Attention Towards Emerging Economies
3.2.1.2 Escalated Innovation Targeting New Therapeutic Solutions
3.2.1.3 Expanded Investments in Technology to Enhance Patient Satisfaction
3.2.2 Market Restraining Factors
3.2.2.1 Elevated Pricing Poses a Constraint on Market Expansion
3.2.2.2 Increased Collaboration for the Development of Advanced Healthcare Infrastructure
3.2.3 Market Opportunities
3.2.3.1 Expansion of Preventative Care Services Tailored to Women's Unique Health Needs.
3.2.3.2 Improving Digital Health Platforms to Enhance the Access to Healthcare Services for Women, Particularly in Underserved Areas.
3.2.3.3 Technological Advancements in Reproductive Health Services, Including Family Planning, Fertility Management, and Maternal Care
3.3 COVID-19 Impact Analysis
3.4 Porter's Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Women's Health Market Analysis by Application
4.1 Key Findings
4.2 Application Segment: Market Attractiveness Index
4.3 Women's Health Market Size Estimation and Forecast by Application
4.4 Contraceptives
4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Postmenopausal Osteoporosis
4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Hormonal Infertility
4.6.1 Market Size by Region, 2024-2034 (US$ Billion)
4.6.2 Market Share by Region, 2024 & 2034 (%)
4.7 Menopause
4.7.1 Market Size by Region, 2024-2034 (US$ Billion)
4.7.2 Market Share by Region, 2024 & 2034 (%)
4.8 Polycystic Ovary Syndrome
4.8.1 Market Size by Region, 2024-2034 (US$ Billion)
4.8.2 Market Share by Region, 2024 & 2034 (%)
4.9 Endometriosis and Uterine Fibroids
4.9.1 Market Size by Region, 2024-2034 (US$ Billion)
4.9.2 Market Share by Region, 2024 & 2034 (%)
4.10 Others
4.10.1 Market Size by Region, 2024-2034 (US$ Billion)
4.10.2 Market Share by Region, 2024 & 2034 (%)
5 Women's Health Market Analysis by Distribution Channel
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Women's Health Market Size Estimation and Forecast by Distribution Channel
5.4 Hospital Pharmacies
5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Retail Pharmacies
5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Online Pharmacies
5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
5.6.2 Market Share by Region, 2024 & 2034 (%)
6 Women's Health Market Analysis by Drugs
6.1 Key Findings
6.2 Application Segment: Market Attractiveness Index
6.3 Women's Health Market Size Estimation and Forecast by Drugs
6.4 Xgeva
6.4.1 Market Size by Region, 2024-2034 (US$ Billion)
6.4.2 Market Share by Region, 2024 & 2034 (%)
6.5 Prolia
6.5.1 Market Size by Region, 2024-2034 (US$ Billion)
6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 Mirena
6.6.1 Market Size by Region, 2024-2034 (US$ Billion)
6.6.2 Market Share by Region, 2024 & 2034 (%)
6.7 Nexplanon
6.7.1 Market Size by Region, 2024-2034 (US$ Billion)
6.7.2 Market Share by Region, 2024 & 2034 (%)
6.8 Forteo
6.8.1 Market Size by Region, 2024-2034 (US$ Billion)
6.8.2 Market Share by Region, 2024 & 2034 (%)
6.9 Nuvaring
6.9.1 Market Size by Region, 2024-2034 (US$ Billion)
6.9.2 Market Share by Region, 2024 & 2034 (%)
6.10 Premarin
6.10.1 Market Size by Region, 2024-2034 (US$ Billion)
6.10.2 Market Share by Region, 2024 & 2034 (%)
6.11 Lupron
6.11.1 Market Size by Region, 2024-2034 (US$ Billion)
6.11.2 Market Share by Region, 2024 & 2034 (%)
6.12 Lo Loestrin
6.12.1 Market Size by Region, 2024-2034 (US$ Billion)
6.12.2 Market Share by Region, 2024 & 2034 (%)
6.13 Orilissa/Oriahnn
6.13.1 Market Size by Region, 2024-2034 (US$ Billion)
6.13.2 Market Share by Region, 2024 & 2034 (%)
6.14 Others
6.14.1 Market Size by Region, 2024-2034 (US$ Billion)
6.14.2 Market Share by Region, 2024 & 2034 (%)
7 Women's Health Market Analysis by Type
7.1 Key Findings
7.2 Application Segment: Market Attractiveness Index
7.3 Women's Health Market Size Estimation and Forecast by Type
7.4 Generic
7.4.1 Market Size by Region, 2024-2034 (US$ Billion)
7.4.2 Market Share by Region, 2024 & 2034 (%)
7.5 Branded
7.5.1 Market Size by Region, 2024-2034 (US$ Billion)
7.5.2 Market Share by Region, 2024 & 2034 (%)
8 Women's Health Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
9 North America Women's Health Market Analysis
9.1 Key Findings
9.2 North America Women's Health Market Attractiveness Index
9.3 North America Women's Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
9.4 North America Women's Health Market Size Estimation and Forecast by Country
9.5 North America Women's Health Market Size Estimation and Forecast by Application
9.6 North America Women's Health Market Size Estimation and Forecast by Distribution Channel
9.7 North America Women's Health Market Size Estimation and Forecast by Drugs
9.8 North America Women's Health Market Size Estimation and Forecast by Type
9.9 U.S. Women's Health Market Analysis
9.10 Canada Women's Health Market Analysis
10 Europe Women's Health Market Analysis
10.1 Key Findings
10.2 Europe Women's Health Market Attractiveness Index
10.3 Europe Women's Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
10.4 Europe Women's Health Market Size Estimation and Forecast by Country
10.5 Europe Women's Health Market Size Estimation and Forecast by Application
10.6 Europe Women's Health Market Size Estimation and Forecast by Distribution Channel
10.7 Europe Women's Health Market Size Estimation and Forecast by Drugs
10.8 Europe Women's Health Market Size Estimation and Forecast by Type
10.9 Germany Women's Health Market Analysis
10.10 France Women's Health Market Analysis
10.11 UK Women's Health Market Analysis
10.12 Italy Women's Health Market Analysis
10.13 Spain Women's Health Market Analysis
10.14 Russia Women's Health Market Analysis
10.15 Poland Women's Health Market Analysis
10.16 Belgium Women's Health Market Analysis
10.17 Rest of Europe Women's Health Market Analysis
11 Asia Pacific Women's Health Market Analysis
11.1 Key Findings
11.2 Asia Pacific Women's Health Market Attractiveness Index
11.3 Asia Pacific Women's Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
11.4 Asia Pacific Women's Health Market Size Estimation and Forecast by Country
11.5 Asia Pacific Women's Health Market Size Estimation and Forecast by Application
11.6 Asia Pacific Women's Health Market Size Estimation and Forecast by Distribution Channel
11.7 Asia Pacific Women's Health Market Size Estimation and Forecast by Drugs
11.8 Asia Pacific Women's Health Market Size Estimation and Forecast by Type
11.9 Japan Women's Health Market Analysis
11.10 China Women's Health Market Analysis
11.11 India Women's Health Market Analysis
11.12 Australia Women's Health Market Analysis
11.13 South Korea Women's Health Market Analysis
11.14 Singapore Women's Health Market Analysis
11.15 Taiwan Women's Health Market Analysis
11.16 Rest of Asia Pacific Women's Health Market Analysis
12 Latin America Women's Health Market Analysis
12.1 Key Findings
12.2 Latin America Women's Health Market Attractiveness Index
12.3 Latin America Women's Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
12.4 Latin America Women's Health Market Size Estimation and Forecast by Country
12.5 Latin America Women's Health Market Size Estimation and Forecast by Application
12.6 Latin America Women's Health Market Size Estimation and Forecast by Distribution Channel
12.7 Latin America Women's Health Market Size Estimation and Forecast by Drugs
12.8 Latin America Women's Health Market Size Estimation and Forecast by Type
12.9 Brazil Women's Health Market Analysis
12.10 Mexico Women's Health Market Analysis
12.11 Argentina Women's Health Market Analysis
12.12 Colombia Women's Health Market Analysis
12.13 Rest of Latin America Women's Health Market Analysis
13 MEA Women's Health Market Analysis
13.1 Key Findings
13.2 MEA Women's Health Market Attractiveness Index
13.3 MEA Women's Health Market by Country, 2024, 2029 & 2034 (US$ Billion)
13.4 MEA Women's Health Market Size Estimation and Forecast by Country
13.5 MEA Women's Health Market Size Estimation and Forecast by Application
13.6 MEA Women's Health Market Size Estimation and Forecast by Distribution Channel
13.7 MEA Women's Health Market Size Estimation and Forecast by Drugs
13.8 MEA Women's Health Market Size Estimation and Forecast by Type
